FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs by FDA.com

Written By Anthony Pizzarelli

For Immediate Release:

June 23, 2023 Agency Recommendations Aim to Inform Psychedelic Drug Development

https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs

Anthony Pizzarelli
Previous

Psychedelic spurs growth of neural connections lost in depression By Bill Hathaway
Next

Psilocybin Shows Early Promise for Anorexia Nervosa Megan Brooks July 25, 2023